TOKYO--(BUSINESS WIRE)--Pharmaceutical services company i3 will announce the expansion of its operations in Japan at a meeting of leading pharmaceutical company executives in Tokyo on July 1. i3 is leveraging the extensive resources of its parent company, UnitedHealth Group (NYSE: UNH), to better serve its Japanese customers, as well as global customers with needs in Japan. UnitedHealth Group is a Fortune 25, $80 billion, global health and well-being leader, employing more than 75 thousand people around the world.